What BMY's 100% Beat Rate Really Tells You
Over the last eight reported quarters, Bristol Myers Squibb (BMY) has beaten the consensus EPS estimate every single time — an 8-for-8 streak with an average earnings surprise of 17.2%. At first glance, that looks like a consistent earnings machine. But the post-earnings price action tells a more complicated story. Across those same eight quarters, the average 5-day price move during the five trading days after each report has been just 0.09%, classified as "flat." In other words, beating estimates has not reliably translated into meaningful directional follow-through. For traders and investors mapping out an earnings calendar, that split between a perfect beat rate and a flat drift is the most important pattern to understand.
Reading the Disconnect Between Beats and Drift
Look at the four most recent reports. On April 30, 2026, BMY reported actual EPS of $1.58 against an estimate of $1.42, an 11.3% beat — yet the stock dropped 3.91% the next day and fell 7.16% over the following five sessions. That is the opposite of the "beat and pop" many expect. By contrast, the February 5, 2026 report saw a smaller 2.4% beat ($1.26 vs. $1.23) deliver a 4.15% next-day gain, though five-day follow-through cooled to just 0.57%. The October 30, 2025 quarter printed a 7.2% beat ($1.63 vs. $1.52) and produced a 0.99% next-day move and a 2.21% five-day move. The largest beat of the four came on July 31, 2025, when actual EPS of $1.46 crushed the $1.09 estimate by 33.9%; the stock rose 2.12% the next day and 4.73% over five days. So the size of the beat alone has not predicted directional persistence. The lesson is that BMY's post-earnings drift has not reliably continued in the direction of the surprise, even on beat quarters.
Options Flow and Technical Context Ahead of July 30
BMY is tentatively scheduled to report before the open on July 30, 2026, with a consensus EPS estimate of $1.59. The stock currently trades at $60.74, with the 50-day EMA at $57.47 and an RSI of 60.9. Heading into the report, options-flow activity is likely to center on implied volatility rather than direction. Traders will compare the straddle or strangle pricing against these historical post-earnings moves. When a stock has beaten estimates 8 out of 8 times with an average surprise of 17.2% but posts a 0.09% average five-day drift, the options market can overprice directional follow-through. Flow may show selling pressure in short-dated premium if the unofficial consensus expects another beat but little follow-through. Conversely, if implied volatility climbs heading into the print, it can signal positioning around a binary event, such as pipeline updates or guidance shifts, rather than just the $1.59 EPS estimate itself.
For a disciplined trader, the key is to separate the headline result from how the market has actually behaved after the result. The 17.2% average surprise and 100% beat rate are historical facts, but the 0.09% average five-day drift is equally real. Watch the deviation from consensus, the immediate next-day reaction, and whether volume confirms any move beyond the $57.47 50-day EMA. For a fuller picture — including how major institutions are currently positioned around the July 30 report and what the latest analyst actions imply — see the full institutional verdict on the BMY research page.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-04-30 | $1.58 | $1.42 | +11.3% | -3.91% | -7.16% |
| 2026-02-05 | $1.26 | $1.23 | +2.4% | +4.15% | +0.57% |
| 2025-10-30 | $1.63 | $1.52 | +7.2% | +0.99% | +2.21% |
| 2025-07-31 | $1.46 | $1.09 | +33.9% | +2.12% | +4.73% |
| 2025-04-24 | $1.8 | $1.49 | +20.8% | - | - |
| 2025-02-06 | $1.67 | $1.47 | +13.6% | - | - |
Get the institutional verdict on BMY
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the BMY verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.